GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer
GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer
Not yet recruiting · NCT07465172 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer | Body Weight, Body Weight Changes, Nausea, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Skin and Connective Tissue Diseases, Vomiting, Weight Loss, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not applicable | 2026-09-30 | NCT07465172 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Breast Cancer Trials, Australia and New Zealand | 6 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Lake Macquarie Private Hospital | Newcastle | Australia | 1 |
| Okayama University Hospital | Okayama | Japan | 75 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |